Product
Help
Pricing
About
Jobs
Log in
Get started
Author
Add to collection
Daniela Gallo
Observed names:
D GALLO,
D Gallo,
D. GALLO,
D. Gallo,
Gallo, Daniela
Institutions:
University of Insubria,
Aziende Socio Sanitarie Territoriale dei Sette Laghi
Observed institutions:
University of Siena,
Università Cattolica del Sacro Cuore,
University of Insubria,
Agostino Gemelli University Polyclinic,
Istituti di Ricovero e Cura a Carattere Scientifico,
Aziende Socio Sanitarie Territoriale dei Sette Laghi,
Pontifícia Universidade Católica de São Paulo
show all 7
ORCID:
0000-0002-1918-1054
Observed ORCID:
0000-0002-1918-1054
OpenAlex ID:
A5023672805
Class III β-Tubulin Overexpression Is a Prominent Mechanism of Paclitaxel Resistance in Ovarian Cancer Patients
2005
·
Simona Mozzetti
, Cristiano Ferlini
, et al.
·
Clinical Cancer Research
·
377
PDF
Clinical Effects of a Standardized Soy Extract in Postmenopausal Women: A Pilot Study
2000
·
Giovanni Scambia
, Daniela Mango
, et al.
·
Menopause The Journal of The North American Menopause Society
·
253
Paclitaxel Directly Binds to Bcl-2 and Functionally Mimics Activity of Nur77
2009
·
Cristiano Ferlini
, Lucia Cicchillitti
, et al.
·
Cancer Research
·
183
PDF
Cells with Characteristics of Cancer Stem/Progenitor Cells Express the CD133 Antigen in Human Endometrial Tumors
2009
·
Sergio Rutella
, Giuseppina Bonanno
, et al.
·
Clinical Cancer Research
·
172
Bcl-2 Down-Regulation Is a Novel Mechanism of Paclitaxel Resistance
2003
·
Cristiano Ferlini
, Giuseppina Raspaglio
, et al.
·
Molecular Pharmacology
·
172
Translational Research in the Era of Precision Medicine: Where We Are and Where We Will Go
2021
·
Ruggero De Maria Marchiano
, Gabriele Di Sante
, et al.
·
Journal of Personalized Medicine
·
143
PDF
The Seco-Taxane IDN5390 Is Able to Target Class III β-Tubulin and to Overcome Paclitaxel Resistance
2005
·
Cristiano Ferlini
, Giuseppina Raspaglio
, et al.
·
Cancer Research
·
115
Antiproliferative and antiangiogenic effects of the benzophenanthridine alkaloid sanguinarine in melanoma
2009
·
Ilaria De Stefano
, Giuseppina Raspaglio
, et al.
·
Biochemical Pharmacology
·
96
Circulating miRNA landscape identifies miR-1246 as promising diagnostic biomarker in high-grade serous ovarian carcinoma: A validation across two independent cohorts
2016
·
Paola Todeschini
, Elisa Salviato
, et al.
·
Cancer Letters
·
87
Antitumour activity of the silybin-phosphatidylcholine complex, IdB 1016, against human ovarian cancer
2003
·
D. Gallo
, S. Giacomelli
, et al.
·
European Journal of Cancer
·
86
Silybin and its bioavailable phospholipid complex (IdB 1016) potentiate in vitro and in vivo the activity of cisplatin
2002
·
Sabrina Giacomelli
, Daniela Gallo
, et al.
·
Life Sciences
·
86
Cytoplasmic expression of estrogen receptor beta (ERβ) predicts poor clinical outcome in advanced serous ovarian cancer
2011
·
Ilaria De Stefano
, Gian Franco Zannoni
, et al.
·
Gynecologic Oncology
·
85
Modulation of basal and squamous cell carcinoma by endogenous estrogen in mouse models of skin cancer
2008
·
M. Mancuso
, D. Gallo
, et al.
·
Carcinogenesis
·
74
Does high-grade endometrioid carcinoma (grade 3 FIGO) belong to type I or type II endometrial cancer? A clinical–pathological and immunohistochemical study
2010
·
Gian Franco Zannoni
, Valerio Gaetano Vellone
, et al.
·
Archiv für Pathologische Anatomie und Physiologie und für Klinische Medicin
·
71
Prognostic significance of the estrogen receptor beta (ERβ) isoforms ERβ1, ERβ2, and ERβ5 in advanced serous ovarian cancer
2014
·
Alessandra Ciucci
, Gian Franco Zannoni
, et al.
·
Gynecologic Oncology
·
70
Dual inhibition of CDK12 and CDK13 uncovers actionable vulnerabilities in patient-derived ovarian cancer organoids
2023
·
Eleonora Cesari
, Alessandra Ciucci
, et al.
·
Journal of Experimental & Clinical Cancer Research
·
64
PDF
Molecular Mechanisms of Patupilone Resistance
2008
·
Simona Mozzetti
, Raffaella Iantomasi
, et al.
·
Cancer Research
·
61
Hyaluronic acid–paclitaxel: effects of intraperitoneal administration against CD44(+) human ovarian cancer xenografts
2010
·
Ilaria De Stefano
, Alessandra Battaglia
, et al.
·
Cancer Chemotherapy and Pharmacology
·
60
Characterization of the pharmacologic profile of a standardized soy extract in the ovariectomized rat model of menopause: effects on bone, uterus, and lipid profile
2005
·
Daniela Gallo
, Gian Franco Zannoni
, et al.
·
Menopause The Journal of The North American Menopause Society
·
60
Estrogen Receptor Beta in Cancer: an Attractive Target for Therapy
2012
·
Daniela Gallo
, Ilaria De Stefano
, et al.
·
Current Pharmaceutical Design
·
57
Reproductive Effects of Dietary Soy in Female Wistar Rats
1999
·
D Gallo
, F Cantelmo
, et al.
·
Food and Chemical Toxicology
·
56
Chemoprevention of DMBA-induced mammary cancer in rats by dietary soy
2001
·
Daniela Gallo
, Sabrina Giacomelli
, et al.
·
Breast Cancer Research and Treatment
·
55
Expression of the Glioma-Associated Oncogene Homolog 1 (Gli1) in Advanced Serous Ovarian Cancer Is Associated with Unfavorable Overall Survival
2013
·
Alessandra Ciucci
, Ilaria De Stefano
, et al.
·
PLoS ONE
·
52
PDF
Preclinical models of epithelial ovarian cancer: practical considerations and challenges for a meaningful application
2022
·
Alessandra Ciucci
, Marianna Buttarelli
, et al.
·
Cellular and Molecular Life Sciences
·
51
PDF
Multiple direct and indirect mechanisms drive estrogen-induced tumor growth in high grade serous ovarian cancers
2016
·
Alessandra Ciucci
, Gian Franco Zannoni
, et al.
·
Oncotarget
·
49
PDF
Show more works
View as search
Works count:
105
Citation count:
3,777
H-index:
36
I10-index:
62
Year
Topic
Type